HIV/AIDS

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

A Conversation about San Francisco’s Health Agenda with Dr. Grant Colfax

Across a wide range of health care issues challenging the U.S., San Francisco  has been at the forefront of identifying and implementing innovative solutions that can influence what other communities do. On Tuesday, June 25, KFF hosted a discussion with San Francisco’s new public health director Dr. Grant Colfax about…

Poll: Most Americans Say HIV Is Serious Issue for the Country as Trump Administration Rolls Out New Plan to End HIV by 2030; Black and Hispanic Adults Report More Personal Concern than White Adults

Support for Medicare-for-all Holds Steady With the Trump administration launching a new domestic HIV effort, the latest KFF Health Tracking Poll finds a large majority of Americans (80%) view the HIV epidemic as a serious national issue, including a third (34%) who view it as “very serious.” Nearly half (46%) view…

Quick Look: Antiretroviral Price Increases in Medicare Part D

Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the federal government if prices increase faster than inflation. We assessed list price changes for ARVs under Part D, which is required to cover all or substantially all ARVs.